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Abstract 
 
 
 
This essay applies the Chronic Care Model, commonly applied to managing diabetes as a 
chronic disease, to substance use disorder through the lens of an inpatient addiction medicine 
consult team. The four components of the Chronic Care Model (increasing provider expertise, 
educating and supporting patients, the use of registry-based information, and the transition to team 
based care) serve as a framework to explore how to create a replicable model for addiction 
medicine treatment in inpatient settings and through integration with non-inpatient care. An 
academic medical center addiction medicine consult service is used to illustrate the administrative 
and operational applications of the Chronic Care Model, with additional illustration of the 
challenges present in creating and sustaining an addiction medicine service line. This is of public 
health importance with the growing population of United States adults with chronic substance use 
disorders. 
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Nomenclature  
 
- OUD: Opioid use disorder   
- MOUD: medication for opioid use disorder  
- MAUD: medication for alcohol use disorder 
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1.0 Background 
Substance use disorder refers to a large group of medical disorders, with a complex 
diagnostic schema. The major classifications of substance use disorder are alcohol use disorder, 
opioid use disorder, cannabis use disorder, cocaine use disorder, polysubstance use disorder, and 
other drug class or chemical use disorders. Addiction can occur at varying levels of substance use 
and presents as a disease state characterized by compulsive and uncontrollable use despite negative 
consequences. Historically, substance use disorders and addiction have been treated as individual 
moral failings and not as chronic medical conditions requiring medical treatment, however, there 
is now ample evidence that substance use disorders and addiction, have strong biological bases 
and represent a spectrum of disease characterized by impaired brain circuitry and impaired 
functioning related to reward, motivation, and memory (American Society of Addiction Medicine, 
2011, n.d.).  Substance use disorders can impact a person at any point in the lifetime and there is 
often a relapsing and remitting course to the disease. Substance use disorder can occur with a 
primary substance or multiple concomitant substances, although the primary substance use 
disorders discussed in this paper are alcohol use disorder and opioid use disorder. These disorders 
are common, with 29.1% of civilian non-institutionalized adults at-risk for developing an alcohol 
use disorder and an estimated 5% of civilian non-institutionalized adults developing an opioid use 
disorder (Grant et al., 2015).  
This paper will focus primarily on the treatment of alcohol use disorder and opioid use 
disorder as chronic diseases that require a continuum of medical services, using the Chronic Care 
Model as a framework. It will discuss the creation and growth of an inpatient addiction medicine 
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consult service in a major academic medical center as part of a continuum of medical and 
psychiatric treatment for substance use disorders.  
1.1 Treatment Options 
The treatment of opioid addiction in the outpatient setting drastically changed over 100 
years ago, when the Supreme Court ruled in 1919 that physicians could not prescribe narcotics to 
patients with a use disorder simply to prevent withdrawal – but physicians could prescribe for the 
purpose of weaning patient use (Priest & McCarty, 2019). Separately, Alcoholics Anonymous 
emerged in 1935 focusing on leveraging community-based support and ego-reduction techniques 
to promote sobriety and achieve abstinence from substance use (Gross, 2010). The early focus of 
opioid treatment was on leveraging a host of behavioral support techniques to promote abstinence, 
followed by the 1974 Narcotics Addict Treatment Act (NATA) which allowed the use of 
methadone for medical treatment and the Drug Addiction Treatment Act of 2000 (DATA) which 
allowed the use of buprenorphine treatment (Ducker, 2015).  
While treatment options have been limited in the last 100 years, standard courses of 
treatment have now emerged and are more readily available in the outpatient setting. Two standard 
classes of medication for opioid use disorder (MOUD) exist: agonist and antagonist drug therapies. 
Agonist drug therapies act on the brain chemically in a similar way to the original chemical 
compound (in this case, an opioid); drugs in this class fulfill the cravings for opioids and allow 
patients to engage with treatment and participate in activities of daily life without engaging in 
drug-seeking behaviors. Antagonist class drugs block the action of the targeted chemical, limiting 
the effect when the chemical is ingested. One of the most common forms of treatment in the United 
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States, buprenorphine, is used to treat opioid use disorder while limiting potential misuse because 
it limits both the risk of respiratory depression and euphoria, even when prescribed at high doses. 
MOUDs are increasingly available in multiple drug and delivery types, with prescription options 
including oral and long-acting injections. There is growing evidence base supporting the use of 
these medications as the “gold standard,” however, few hospital systems routinely prescribe these 
medications to eligible patients during admission (Mattick, Breen, Kimber, & Davoli, 2014) 
(Rosenthal, Karchmer, Theisen-Toupal, Castillo, & Rowley, 2016).   
Medication for alcohol use disorder is more limited, with only two drugs rated as 
consistently evidenced-based by the American Academy of Family Physicians; these two drugs 
are acamprosate and naltrexone (Winslow, Onysko, & Hebert, 2016). In any use disorder, 
medication alone is not a solution to recovery and all professional societies further recommend 
medication in addition to psychotherapy and engagement with a therapeutic environment. 
Wraparound supports, both in community and health modification are necessary to have lifelong 
recovery and abstinence.   
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2.0 Models of Care 
The treatment of substance use disorder has followed a similar path to the history of the 
field outlined above. In the beginning stages of the field of addiction medicine, treatments for 
substance use disorder were episodic, with a focus on inpatient rehabilitation with little-to-no 
connection to ongoing outpatient maintenance (Gross, 2010). As maintenance medications have 
become more available and the evidence-base supporting their use grows, a more chronic care 
management approach has developed, though it is still developing in terms of national 
standardization of care. The chronic care model has been applied to other disease states, notably 
diabetes, and has four components for health systems and six components in clinical practice. The 
four characteristics that apply to health systems include increasing provider expertise, educating 
and supporting patients, making use of registry-based information, and making care delivery more 
team-based and planned (Coleman, Austin, Brach, & Wagner, 2009).  This paper will focus on 
how each of the four components of the Chronic Care Model is addressed in the best practices of 
an addiction medicine service. This paper will also highlight the presence of elements that are 
predictive of a successful chronic care model, including self-management support, decision 
support, health care organization support, and connections to community resources (Coleman et 
al., 2009). The components and elements are described in Table 1.  
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Table 1 Chronic Care Model: Components and Elements 
Four Components Six Elements 
Increase provider expertise Self-management support 
Educate and support patients Decision support 
Use registry-based information 
Health care organization support 
Connection to community resources 
Make care more team based 
Delivery system design 
Clinical information systems 
 
2.1 The Chronic Care Model Applied to Addiction Medicine: A Case Study 
Since 2000, medication therapies to treat opioid use disorder have been made more 
available and trained providers have been able to treat opioid use disorder in a medical setting as 
a chronic disease. The medical community has been working to increase provider capacity in use 
of these medications and other therapeutic options to treat the disease of substance use disorder, 
and particularly opioid use disorder (“The Evolution of Addiction Medicine as a Medical 
Specialty,” 2011). 
In 1990, addiction medicine became a recognized specialty through the American Medical 
Association, with a board certification option to follow nearly 20 years later (“The Evolution of 
Addiction Medicine as a Medical Specialty,” 2011). The last 20 years have been a crucible for 
addiction medicine, both in epidemiologic need in the United States and in evidence-based practice 
development in treating addiction. The American Board of Addiction Medicine did not award the 
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first board certifications until 2009. In the last decade, capacity has been grown for the field 
through the creation of fully accredited addiction medicine fellowships; 10 such residencies 
existed in 2011, with an additional 23 programs added by 2019 (“Number of Fellowships Growing 
with ACGME Accreditations—American College of Academic Addiction Medicine American 
College of Academic Addiction Medicine,” n.d.). Through 2021, medical doctors will be allowed 
to substitute treatment hours and additional training in addiction medicine in a non-fellowship 
setting to apply for a board in addiction medicine; it is critical that existing addiction medicine 
programs in internal medicine and toxicology enthusiastically support their medical providers in 
pursuit of this board certification. The previously listed areas speak to the professionalization of 
the field of addiction medicine and the robust fulfillment of the first principle of the chronic care 
model, the development of provider expertise.  The case study hospital discussed here is in the 
process of forming the first accredited addiction medicine fellowship in the region, which will be 
critical to the long-term sustainability of the addiction medicine services offered.  
Provider expertise does not just extend to medical doctors in this model. Analogous to the 
role of certified diabetes nurse educators, addiction medicine has broadened the scope of specialty 
providers to include certified addiction medicine nurses. Starting in 2000, the Addictions Nursing 
Certification Board (ANCB) began certifying nurses with additional training and has certified 
more than 1900 nurses in the US as of December 2018, using the title Certified Addictions 
Registered Nurses (CARN) (“CARN and CARN-AP receives ABSNC accreditation | IntNSA,” 
n.d.). Critically, this certification program broadens the impact of professional training in the field 
of addiction medicine and additionally offers nurses in recovery an opportunity to join their unique 
experience with a chronic disease with their clinical bedside practice. Addiction medicine training 
exists for individuals in recovery without a clinical background in the form of state-level Certified 
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Recovery Specialist programs; these programs require more than 50 hours of classroom training 
in addition to 18 continues months of recovery prior to enrollment. As of 2017, there were 896 
actively licensed Certified Recovery Specialists (CRS) in Pennsylvania (the state of interest in this 
case study) (Department of Drug and Alcohol Programs, 2017).  
These CRS positions are critical in the second tenet of the Chronic Care Model application 
to addiction medicine: supporting and educating the patient. CRSs are engaged in many national 
treatment models for addiction medicine because of the critical role a person in recovery can have 
in providing support for both initial and on-going therapeutic engagement. The only literature on 
establishing an addiction medicine service lists the CRS position as not only critical for patient 
support and education, but also engagement of community programs and support (Englander et 
al., 2017).  
The third component of the chronic care model is the registration of patients for on-going 
tracking. In the model implemented at the case subject hospital, all patients who received an 
intervention from the addiction medicine consult service were tracked in two ways: concurrently 
by the team social worker in a HIPAA secure and team-shared non-electronic health record source 
and retrospectively in a health-system level reporting database that linked to post-admission 
outcomes information (e.g., engagement with the primary care provider of record, hospital 
readmission within 7 and 30 days). The concurrent tracking completed by the social worker allows 
the team to understand clinical and psycho-social needs in one clearly summarized area, instead 
of completing extensive chart review to determine discharge plans, insurance status, or previous 
engagement with addiction medicine outside of the hospital context. This concurrent information 
is also used administratively to support financial planning for the service line, philanthropic 
activities in support of the service, and in staffing planning based on demand for addiction 
 8 
medicine services.  Retrospective data is then added to this registry of patients for further analysis 
about impact and to address disease-specific relevant issues (e.g., proportion of population with 
alcohol use disorder or opioid use disorder).    
The fourth element of the chronic care model is to make care more team based and 
planned. The case hospital has worked since 2017 to develop an addiction medicine service line 
to complement the existing addiction psychiatry and toxicology service lines that offer addiction 
treatment to patients. To establish the service line, a national physician leader was recruited with 
knowledge of how to establish a continuum of care for addiction medicine, including inpatient 
addiction consult services and the linkage to outpatient addiction medicine treatment. In October 
2018, together with support from toxicology and psychiatry consult liaison services, an addiction 
medicine consult service was launched as a pilot limited to two internal medicine units. The service 
was staffed by an attending physician with the support of a full-time CRS and a part-time social 
worker. In March 2019, a CARN-certified RN was hired to support the growth of the team and the 
service was expanded to serve the more than 750 licensed beds in the facility. During the pilot 
phase, the addiction medicine inpatient consult service averaged 20 patients per month; after 
expanding beyond the pilot units and with the additional staffing resources, the service quickly 
grew to serve between 70 and 80 patients monthly.   
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3.0 Staffing an Addiction Medicine Consult Service  
Rapid growth in demand for services has resulted in clinical and administrative growing 
pains to provide consistent addiction medicine consult coverage. Clinically, the post-hospital 
placement of patients with complex psycho-social needs or patients on specific forms of 
medication for opioid use disorder has proven to be a consistently challenging problem because of 
the lack of community placement options and high administrative burden to coordinate placement. 
Patients with a history of intravenous drug use who require long-term intravenous antibiotic 
therapy for infections are often ineligible to receive care in skilled nursing facilities, often requiring 
a high-resource six-week hospitalization. Additionally, linking patients to a state-certified drug 
and alcohol provider in their county of residence can be challenging when there may be only one 
provider with limited capacity to engage new patients.  
Administratively, the growth of the service and the general lack of evidence-based 
approaches to hospital-based addiction medicine services has resulted in extended justifications 
for financial or administrative resources. Internal benchmarking with other non-procedural 
services has been a successful approach to supplementing national staffing benchmarking available 
for toxicology and palliative care consult services. Internal interviews were conducted for 
benchmarking with the psychiatry consult liaison service and the palliative medicine services. In 
both cases, these services closely mirror the care provided by the addiction medicine service 
because they are non-primary services (they only offer a consultative opinion to the primary 
medical or surgical team) but the services link patients with outpatient continuation of treatment. 
Additionally, these services both involve lengthy face-to-face interviewing of the patient and 
supportive family members. In these conversations about benchmarking, the administrative team 
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for addiction medicine generated staffing standards on the following outcomes: expected number 
of patients to be billed per day and the ratios of medical providers to nursing staff.  In Table 2, the 
results of this internal and external benchmarking are shown. In general, services expected their 
providers to bill for at least 6 face-to-face patient encounters daily, or 30 patient encounters weekly 
to support a full time clinical medical staff member, with an average frequency of visits being 
every 3 days for those clinical services that reported.  
 
Table 2 Staffing for an Addiction Medicine Service 
 Expected patients 
per day per MD 
Expected Frequency 
of Care 
MD:RN 
Ratio 
Psychiatry Consult 
Liaison 
(Internal) 
6 Every 3 days (~2-3 
consults per hospital 
stay) 
.08:1.0 FTE 
Palliative Care 
(Internal) 
8 Not reported Not 
applicable. 
Palliative Care 
(Henderson et al., 2019) 
5 Not reported 1.0: 1.0 FTE 
Toxicology 
(Wiegand et al., 2015) 
6 2 consults per 
hospitalization 
Not 
applicable 
 
A national study in the Canadian health system supports this approach to staffing for 
palliative care services, citing two approaches to staffing models. The first approach suggests a 
NCBDE 1.0 MD full time equivalent with a 1.0 nursing full time equivalent to support 25 consults 
per month, when using a hospital-based consult model (as is true in the addiction medicine consult 
model); the second approach suggests the same ratio of providers per six palliative/hospice care 
level beds for a unit-driven staffing model (Henderson et al., 2019). External benchmarking of a 
New York State based toxicology consult service supported assumptions about the frequency of 
consult services and general volume estimates of monthly consults based on a large academic 
teaching hospital with more than 800 licensed beds. In this study, the consult service saw on 
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average 80 initial consults monthly with a similar volume of subsequent consult follow up visits, 
each taking on average one hour of physician time to complete (Wiegand et al., 2015). In the 
toxicology consult service, no supportive staff members were included in the efficiency or cost 
model and could not be reported as part of a staffing ratio.  
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4.0 Constraints in Applying the Chronic Care Model to Addiction Medicine Nationally 
Addiction medicine is a developing field, primarily growing and flourishing in high-
resource academic settings. Substance use disorder is a national clinical problem, and an 
increasingly rural challenge. Each year, the economic burden of the substance use disorders 
exceeds $400 billion (NIDA, 2017). This exceeds the estimated $327 billion spent each year on 
the diagnosis, treatment, and overall reduced productivity of Type I and Type II Diabetes in the 
United States (American Diabetes Association, 2018). While the development of a full chronic 
care model within diabetes has been largely seen as successful and diabetes is used as the general 
use-case for the chronic care model, this same model has not been widely applied to addiction 
medicine diagnosis and treatment. One of the major challenges to the broad application of the 
chronic care model to addiction medicine is the current centrality of addiction treatment in urban 
and academic-based healthcare settings, unlike diabetes which is successfully managed in lower-
resource primary care settings in non-urban or non-academic settings.  
4.1 Challenges in Implementing Chronic Care Addiction Medicine 
In the current reimbursement climate and increasingly stretched hospital system margins, 
it can be challenging to identify opportunities to financially support a human capital-intensive 
service like addiction medicine. The payer mix for patients within addiction medicine is rarely 
favorable towards commercial insurance products with high-reimbursement, leaving shortfalls 
between the high cost of clinical staff and the low reimbursement for patients with complex 
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coordination needs. Additionally, unlike a chronic care population with diabetes, there is not yet a 
robust system of outpatient providers with the interest and expertise to manage patients with 
complex substance use disorder in a standard outpatient setting. This is due in part to regulatory 
issues that have persisted for 100 years since the 1919 court ruling limiting the use of medication 
for opioid use disorder. In modern day this manifests as the X-Waiver restriction that requires 
providers to complete extensive training prior to prescribing patients buprenorphine, a prescription 
commonly used to support patients in recovery from opioid use disorder. In order to appropriately 
generate a return-on-investment for an addiction medicine service, extensive data supports are 
required to build a financial case on other metrics. These other metrics can include hospital length 
of stay, reduced hospital and emergency department readmissions, and decreased mortality. The 
case hospital discussed in this paper is currently partnering with biostatisticians to build a model 
for assessing the impact of the addiction medicine consult service prior to submitting funding 
requests for on-going financial support. Not all hospitals will have access to biostatistical resources 
that are available to academic clinicians at a major academic medical center. 
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5.0 Conclusion 
In order to address the national crisis in managing chronic and acute substance use disorder, 
healthcare resources must respond by acknowledging that substance use disorder is a chronic 
disease and use evidence-based structures for chronic care management. In applying the core 
structures of the chronic care model that has improved care for diabetic patients in the United 
States to substance use disorder, there are additional opportunities to grow and develop the 
provider teams that care for substance use disorder patients. Addiction medicine consult services 
should be a core part of this service growth and professionalization, as these hospital-based teams 
can serve as a critical touchpoint for patients and for other providers. Addiction medicine consult 
services can also be piloted without substantial resource commitments. It has been shown that 
these consult services stabilize in patient volumes within a year of starting the consult service 
((Wiegand et al., 2015), (Englander et al., 2017)). While these inpatient addiction consult services 
improve coordination of care, they also have been shown to improve patient engagement with 
treatment upon discharge for opioid use disorder patients (Liebschutz et al., 2014). The creation 
of a standard addiction medicine consult infrastructure will serve as a national backbone in the 
application of a chronic care model to substance use disorder. 
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5.1 Recommendations 
Effective dissemination of best practices from the hospital-based chronic care model of 
addiction medicine will require continued and sustained growth in the field. This growth must be 
multidisciplinary in nature, with clinical exposure to addiction medicine for trainees in medical 
schools, nursing schools, and schools of social work. In the program discussed here, trainees from 
schools of medicine, nursing, social work, and pharmacy rotate through the inpatient and 
outpatient addiction medicine services and gain valuable exposure to addiction medicine. Growing 
the field of addiction certified nurses from the current 1,000 will also be beneficial for the overall 
application of the chronic care model outside of the hospital setting. As a point of comparison, in 
2016 there were 9,834 certified diabetes nurse educators in the United States (“2016 Count of 
CDEs by State and Other Statistics”, 2016). This specialized role for nursing fulfills three of the 
four core tenets of the chronic care model: increasing provider expertise, improving patient 
education about their disease state, and improving team-based care. In addition to growing the 
number of board-certified addiction medicine medical doctors, substantial effort should be made 
to increase the number of CARN certified nurses and nurse practitioners across the country.   
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6.0 Academic Experience  
As a student through my administrative residency with the Department of Medicine, I was 
able to serve as an administrative support to the development of the Addiction Medicine Consult 
Service at UPMC Presbyterian. This experience allowed me to practice a variety of administrative 
skills, including scheduling physicians, procuring resources, and managing partnerships with other 
medical subspecialties. As the administrative resident, I was able to manage unique pay 
arrangements for involved physicians, produce financial proformas to hire physicians and 
advanced practice providers, and evaluate on-going financial performance. This experience 
quickly and robustly developed my understanding of hospital finance, medical billing and coding, 
and physician compensation.  
Working with providers in addiction medicine across the Division of General Internal 
Medicine and providers in Medical Toxicology in the Department of Emergency Medicine was 
incredibly educational in approaches to care for patients with substance use disorder. Medical 
providers were generous to educate me to the types of addiction medicine services that could be 
provided and about the importance of reducing stigma for this at-risk population. My 
administrative learning experience was only eclipsed by my education in the work medical 
providers and the multidisciplinary team provide to patients who are seeking to live a healthier 
life. The persistence in the patients receiving treatment and the providers giving care was 
perspective-changing and illustrated the best of what medical care can be.  
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